Sharma, Dipali <br/><br/>
Adiponectin antagonizes the oncogenic actions of leptin in hepatocellular carcinogenesis.  [electronic resource] 

 -  Hepatology (Baltimore, Md.)  Nov 2010 
 - 1713-22 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1527-3350 
<br/><br/><label>Standard No.: </label>10.1002/hep.23892  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adiponectin--therapeutic use<br/>Animals<br/>Apoptosis--drug effects<br/>Carcinoma, Hepatocellular--epidemiology<br/>Cell Division--drug effects<br/>Cell Line, Tumor<br/>Cell Movement<br/>DNA, Neoplasm--analysis<br/>Humans<br/>Immunohistochemistry<br/>In Situ Nick-End Labeling<br/>Leptin--antagonists & inhibitors<br/>Liver Neoplasms--epidemiology<br/>Mice<br/>Mice, Nude<br/>Obesity--complications<br/>Phosphorylation<br/>Transplantation, Heterologous